• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204
Citation: MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204
shu

Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives

More Information
    Graphical Abstract
    • Abstract
  • A series of farnesylthiosalicylamide derivatives( 9a-9k )were designed and synthesized via condensating the carboxyl of farnesylthiosalicylic acid(FTS)with different amines, and the in vitro biological activity was evaluated. It was observed that eight of them displayed strong antitumor activity against five human cancer cells in vitro. Notably, compound 9k exhibited the most active with the IC50 values of 6. 05-8. 16 μmol/L range against the tested cancer cells, which were superior to those of FTS and even comparable to that of sorafenib in vitro. In addition, compound 9k down-regulated the protein of Bcl-2 and increased the expression levels of Bax and caspase-3 proteins, indicating that compound 9k could induce tumor cell apoptosis.
    • FullText(HTML)
    • References (13)
  • [1]
    Vigil D,Cherfils J,Rossman KL,et al.Ras superfamily GEFs and GAPs:validated and tractable targets for cancer therapy[J].Nat Rev Cancer,2010,10(12):842-857.
    [2]
    Goitre L,Trapani E,Trabalzini L,et al.The Ras superfamily of small GTPases:the unlocked secrets[J].Methods Mol Biol,2014,1120(12):1-18.
    [3]
    Bos JL.Ras oncogenes in human cancer:a review[J].Cancer Res,1989,49(17):4682-4689.
    [4]
    Adjei AA.Blocking oncogenic Ras signaling for cancer therapy[J].J Natl Cancer Inst,2001,93(14):1062-1074.
    [5]
    Takashima A, Faller DV. Targeting the RAS oncogene[J].Expert Opin Ther Targets,2013,17(5):507-531.
    [6]
    Marciano D,Ben-Baruch G,Marom M,et al.Farnesyl derivatives of rigid carboxylic acids inhibitors of ras-dependent cell growth[J].J Med Chem,1995,38(8):1267-1272.
    [7]
    Riely GJ,Johnson ML,Medinaetal C,et al.A phase II trial of salirasib in patients with lung adenocarcinomas with KRAS mutations[J].J Thorac Oncol,2011,6(8):1435-1437.
    [8]
    Charette N,De Saeger C,Horsmans Y,et al.Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms[J].Cell Death Disease,2013,4(1):e471.
    [9]
    Mologni L,Brussolo S,Ceccon M,et al.Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells[J].PLoS One,2012,7(12):e51449.
    [10]
    Haklai R,Elad-Sfadia G,Egozi Y,et al.Orally administered FTS(salirasib)inhibits human pancreatic tumor growth in nude mice[J].Cancer Chemother Pharmacol,2008,61(1):89-96.
    [11]
    St Jean DJ Jr,Fotsch C.Mitigating heterocycle metabolism in drug discovery[J].J Med Chem,2012,55(13):6002.
    [12]
    Ling Y,Wang ZQ,Zhu HY,et al.Synthesis and biological evaluation of farnesylthiosalicylamides as potential anti-tumor agents[J].Bioorg Med Chem,2014,22(1):374-380.
    [13]
    Wang ZQ,Wang XM,Zhang W,et al.Synthesis and biological evaluation of novel farnesylthiosalicylic acid/hydroxylcinnamic acid hybrids as potential anti-tumor agents[J].J China Pharm Univ(中国药科大学学报),2014,45(3):392-399.
    • Related Articles

  • Related Articles

    [1]ZHANG Xueling, LI Na, CHEN Li. Progress of research on celastrol derivatives as anti-tumor agents[J]. Journal of China Pharmaceutical University, 2024, 55(6): 826-836. DOI: 10.11665/j.issn.1000-5048.2023041802
    [2]ZHANG Wanyue, LIU Wei, XU Hang, GAO Xiangdong. Advanced structure analysis and structure-activity relationship of polysaccharide SGP-2 from Sarcandra glabra[J]. Journal of China Pharmaceutical University, 2021, 52(5): 630-635. DOI: 10.11665/j.issn.1000-5048.20210517
    [3]LIU Haomiao, HU Xiaowen, ZHOU Jinpei, ZHANG Huibin. Advances of G protein coupled receptor 119 agonists and their structure-activity relationship[J]. Journal of China Pharmaceutical University, 2013, 44(1): 11-19. DOI: 10.11665/j.issn.1000-5048.20130102
    [4]ZHENG Kai-bo, SUN Cheng-bin, MAO Hai-li, YANG Zai-bo. Progress in the research of chemical structural modification of ursolic acid and structure-activity relationship[J]. Journal of China Pharmaceutical University, 2009, 40(6): 580-584.
    [5]Progress of the Classification of β-lactamases and Its Relationship Between Structure and Function[J]. Journal of China Pharmaceutical University, 2003, (4): 90-94.
    [6]Structure-Cytotoxic Activity Relationships of Diterpenoid Tanshinones from Salvias[J]. Journal of China Pharmaceutical University, 2002, (1): 8-14.
    [7]Synthesis, Analgesic Activity and Structure-Activity Relationship of 4-N-Cyclohexyl Analogs of Some Fentanyl Derivatives[J]. Journal of China Pharmaceutical University, 1993, (3): 139-144.
    [8]Structural-Activity Relations Study on the Derivatives of 3,4-Dimethoxyphenylenediamine[J]. Journal of China Pharmaceutical University, 1992, (4): 217-220.
    [9]DETERMINATION OF HYDROLYSIS RATE AND PRELIMINARY STRUCTURE-ACTIVITY RELATIONSHIP OF THIOHYDANTOIN DERIVATIVES[J]. Journal of China Pharmaceutical University, 1989, (4): 199-202.
    [10]RELATIONSHIP BETWEEN STRUCTURE AND ANTIBACTERIAL ACTIVITIES OF TANSHINONES AND RELATED COMPOUNDS[J]. Journal of China Pharmaceutical University, 1988, (4): 258-262.

  • Cited by

    Periodical cited type(1)

    1. 苏琦，张珂，黄淑琪，朱希强，刘晓鹏，姜宁. 逆境胁迫对药用植物药效成分积累的影响. 湖北民族大学学报(自然科学版). 2022(02): 129-134+180 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (1096) PDF downloads (1678) Cited by(1)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365893

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return